Navigation Links
Everolimus slows disease progression in advanced papillary kidney cancer patients
Date:9/27/2013

-free survival was 7.6 months, according to the central review it was 3.7 months, and more than half of the patients were alive at 21 months.

"These results underline the differences that are often observed between local investigator assessment and central review according to the established set of rules used to evaluate anti-cancer drugs.

"As far as we know, this study is unique as it was the first study of an mTOR inhibitor to only include patients with advanced papillary kidney cancer and diagnosis was also confirmed by an independent group of pathologists experienced in the classification of kidney cancer to prevent any tumours being classified incorrectly.

"Everolimus represents another interesting treatment option for advanced papillary kidney cancer patients as it seems to extend their survival and time without the disease progressing."

Adverse side-effects were generally well tolerated. They included weakness, tiredness and anaemia; 27% of patients discontinued everolimus due to these side-effects. "The typical patient being treated for advanced papillary kidney cancer is middle-aged, active and still working, and the impact of side-effects may be more important to them," he will say.

"While the results from this Phase II study are encouraging, a Phase III trial would need to be done to fully characterise the efficacy and safety profile of everolimus in this patient population," he will conclude.

President of ECCO, Professor Cornelis van de Velde, commented: "Papillary tumours have been excluded from many of the targeted therapy trials. This study on targeting the mTOR pathway in patients with advanced papillary kidney cancer provides a basis for a Phase III trial and is potentially practice changing. It also emphasises the need for expert pathology, since central review gave markedly different results than local review."

ESMO spokesperson, Professor Manuela Schmidinger, Professor of Medicine
'/>"/>

Contact: Kay Roche
kay@rochewriting.com
ECCO-the European CanCer Organisation
Source:Eurekalert

Page: 1 2 3 4

Related medicine news :

1. Thwarting protein production slows cancer cells malignant march
2. Aging - Daily Sunscreen Use Slows the Visible Signs of Aging Skin
3. Skin Care – Sunscreen Slows Skin Aging
4. Skin Care – Daily Sunscreen Use Slows Skin Aging
5. Scientists discover how rapamycin slows cell growth
6. Treatment with A1-PI slows the progression of emphysema in Alpha-1 antitrypsin deficiency
7. Low-protein diet slows Alzheimers in mice
8. Newly approved oral medication slows rheumatoid arthritis joint damage
9. Active lifestyle boosts brain structure and slows Alzheimer’s disease
10. Mesothelioma drug slows disease progression in patients with an inactive NF2 gene
11. Mild HIV type slows development of AIDS and makes new preventive treatments possible
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)... Chicago, IL (PRWEB) May 27, 2015 The ... Chicago office is open for business to better serve ... is in the Jefferson Park neighborhood on the Northwest side ... Chicago. Appointments can be arranged by calling the Chicago ... location for the Advanced Fertility Center of Chicago. The ...
(Date:5/26/2015)... May 27, 2015 Bellabeat, a ... for women, today announces the LEAF , ... stress, sleep, activity and ovulation. The LEAF seamlessly ... health tracking technolo- gy, particularly its mechanism for ... provide women with lifestyle data and recommendations through ...
(Date:5/26/2015)... 27, 2015 The world of cosmetic ... ’s quest to remain on the cutting edge of ... the many new additions to plastic surgery and his ... surgical procedures, with emphasis on facelifts and mommy-makeovers all ... very user friendly and easy to navigate. The sites ...
(Date:5/26/2015)... Meadows, Ill. (PRWEB) May 26, 2015 ... cosmetic procedures in 2014, according to survey results released ... With increases in skin cancer treatments and several cosmetic ... years ago but remained steady overall compared to 2013 ... row, skin cancer treatments ranked as the most-performed procedure ...
(Date:5/26/2015)... 2015 Now offering innovative, safe, and ... of Dr. Hedi Belajouza in Tunisia extends ... Perfection to the last detail — meticulous hair placement, ... of the harvested follicle — are all results in ... visible in the artistry and talent of Tunisian hair ...
Breaking Medicine News(10 mins):Health News:The Advanced Fertility Center of Chicago Opens a New Fertility Office Location in Chicago 2Health News:Bellabeat debuts the LEAF - smart jewelry that monitors women’s health. 2Health News:Bellabeat debuts the LEAF - smart jewelry that monitors women’s health. 3Health News:Miguel Delgado, M.D. Launches Two New Plastic Surgery Websites 2Health News:Miguel Delgado, M.D. Launches Two New Plastic Surgery Websites 3Health News:New ASDS Survey: 9.5 Million Treatments Performed in 2014 2Health News:New ASDS Survey: 9.5 Million Treatments Performed in 2014 3Health News:New ASDS Survey: 9.5 Million Treatments Performed in 2014 4Health News:Hair Transplant Center in Tunisia Now Offering Innovative Restoration Technology 2Health News:Hair Transplant Center in Tunisia Now Offering Innovative Restoration Technology 3Health News:Hair Transplant Center in Tunisia Now Offering Innovative Restoration Technology 4
... Hospitals need a "civility initiative.",According to a new ... to go,beyond traditional customer service programs and evaluate ... white paper, "Character Counts:,Integrating Civility into the Healthcare ... Modern Healthcare and frequent author and speaker. The,paper ...
... won 1st Place as "Best Website for International ... Awards event in the US capitol. Bumrungrad.com is ... expatriates. The Award organizers said the site ... the information they are interested in, provide an ...
... With President Obama preparing to,present his budget proposal, which ... stimulus initiatives and a renewed call for healthcare reform,the ... data,on how the most comprehensive healthcare fix would create ... , Overall, expanding and upgrading ...
... factor 8 and 9 are first target indicationsHOUSTON, Feb. ... assist device program has additional application in the production ... commercially important therapeutic proteins are liver products and comprise ... H. Kelly, CEO of SCLL. "Albumin, the clotting ...
... , , , , , , , , ... , , , , ... , , ... and director of MUM,s Center for Brain, ,Consciousness and Cognition, discusses this first random assignment study of ,the effects of meditation ...
... Sopherion Therapeutics, LLC, a biopharmaceutical company focused ... has announced the appointment of Dr. Marcel Rozencweig ... Prior to joining Sopherion, Dr. Rozencweig was a ... a member of the Sopherion Protocol Development Team ...
Cached Medicine News:Health News:Where's the Civility in Healthcare? New White Paper from The Beryl Institute Explores Why Character Counts in Healthcare 2Health News:Bumrungrad International Hospital Won 1st Place as "Best Website for International Medical Travel" 2Health News:Stem Cell Innovations' C3A Human Liver Cell Line is Capable of Producing Biosimilar Serum Proteins for Follow-On Biologics 2Health News:Stem Cell Innovations' C3A Human Liver Cell Line is Capable of Producing Biosimilar Serum Proteins for Follow-On Biologics 3Health News:Transcendental Meditation buffers students against college stress: Study 2Health News:Transcendental Meditation buffers students against college stress: Study 3Health News:Transcendental Meditation buffers students against college stress: Study 4Health News:Transcendental Meditation buffers students against college stress: Study 5Health News:Sopherion Therapeutics Announces Appointment of New Senior Executive Vice President for Clinical Affairs 2
(Date:5/26/2015)... 2015 Cellular testing for ... the future of technologies for screening cells? Now ... Stay ahead there for data, benefiting your influence. ... R&D, opportunities and revenue forecasts. That ... what,s possible for cell-based assays and ...
(Date:5/26/2015)... -- ViiV Healthcare, Aurobindo Pharma, and the ... Aurobindo Pharma has submitted an Abbreviated New Drug Application ... Food and Drug Administration (FDA), for the treatment of ... version of dolutegravir, less than two years after FDA ... the United States . Upon receiving ...
(Date:5/26/2015)... NEW YORK , May 26, 2015   ... Flatiron Health today announced a strategic ... electronic health record (EHR), data analytics and decision support ... the companies will build upon their existing respective software ... oncology and data analytics product suite. ...
Breaking Medicine Technology:Cell-Based Assays: World Industry and Market Prospects 2015-2025 2Cell-Based Assays: World Industry and Market Prospects 2015-2025 3Cell-Based Assays: World Industry and Market Prospects 2015-2025 4Cell-Based Assays: World Industry and Market Prospects 2015-2025 5Cell-Based Assays: World Industry and Market Prospects 2015-2025 6Cell-Based Assays: World Industry and Market Prospects 2015-2025 7ViiV Healthcare and CHAI Collaboration Delivers Second Milestone With First Filing With the FDA of Generic Dolutegravir by Aurobindo Pharma for the Treatment of HIV 2ViiV Healthcare and CHAI Collaboration Delivers Second Milestone With First Filing With the FDA of Generic Dolutegravir by Aurobindo Pharma for the Treatment of HIV 3ViiV Healthcare and CHAI Collaboration Delivers Second Milestone With First Filing With the FDA of Generic Dolutegravir by Aurobindo Pharma for the Treatment of HIV 4ViiV Healthcare and CHAI Collaboration Delivers Second Milestone With First Filing With the FDA of Generic Dolutegravir by Aurobindo Pharma for the Treatment of HIV 5ViiV Healthcare and CHAI Collaboration Delivers Second Milestone With First Filing With the FDA of Generic Dolutegravir by Aurobindo Pharma for the Treatment of HIV 6ViiV Healthcare and CHAI Collaboration Delivers Second Milestone With First Filing With the FDA of Generic Dolutegravir by Aurobindo Pharma for the Treatment of HIV 7Varian Medical Systems and Flatiron Health to Develop Next Generation of Cloud-based Oncology Software 2Varian Medical Systems and Flatiron Health to Develop Next Generation of Cloud-based Oncology Software 3Varian Medical Systems and Flatiron Health to Develop Next Generation of Cloud-based Oncology Software 4
...
...
...
Open blade speculum designed for both temporal and superior approach ocular surgery. Thumb screw adjusting mechanism. Manufactured in titanium....
Medicine Products: